Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30555165

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2019 Feb
First author
Cortes JE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Cortes JE
      type
      Author
    2. name
      Heidel FH
      type
      Author
    3. name
      Hellmann A
      type
      Author
    4. name
      Fiedler W
      type
      Author
    5. name
      Smith BD
      type
      Author
    6. name
      Robak T
      type
      Author
    7. name
      Montesinos P
      type
      Author
    8. name
      Pollyea DA
      type
      Author
    9. name
      DesJardins P
      type
      Author
    10. name
      Ottmann O
      type
      Author
    11. name
      Ma WW
      type
      Author
    12. name
      Shaik MN
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Cortes JE
      type
      Author
    2. name
      Heidel FH
      type
      Author
    3. name
      Hellmann A
      type
      Author
    4. name
      Fiedler W
      type
      Author
    5. name
      Smith BD
      type
      Author
    6. name
      Robak T
      type
      Author
    7. name
      Montesinos P
      type
      Author
    8. name
      Pollyea DA
      type
      Author
    9. name
      DesJardins P
      type
      Author
    10. name
      Ottmann O
      type
      Author
    11. name
      Ma WW
      type
      Author
    12. name
      Shaik MN
      type
      Author
    bibliography ids
    1. nci-bib-ae19f85f1c1a6e4c1f81027d
    book metadata
    content sha256
    7e3871a865e212f7b27dd0bea90c936def023f859da26fe1d3063fef932693dd
    document type
    citation
    dois
    1. 10.1038/s41375-018-0312-9
    electronic publication date
    display
    2018 Dec 16
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30555165
    immutable id
    pubmed:30555165@7e3871a865e212f7b27dd0bea90c936def023f859da26fe1d3063fef932693dd
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    2
    name
    Leukemia
    nlm unique id
    8704895
    pages
    379-389
    volume
    33
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30555165
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      fefebe4b47a91704e0066de148c3af26b853fb915eea0bcf2e0561f34b1cbadb
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2019 Feb
      precision
      month
      year
      2019
      publication types
      1. Clinical Trial, Phase II
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30555165/
      title
      Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.

      Preserved source evidence · Not medical advice